Protalix Biotherapeutics, Inc. [PLX] has reported $3.7 million in revenue TOTAL REVENUE for Q4 ended Dec 31, 2022.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss NET LOSS FOR THE PERIOD for the quarter was $4.6 million.
Also Read:
Based in HACKENSACK, New Jersey, Protalix Biotherapeutics, Inc. operates in the Manufacturing sector.
Related Articles: